Background Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age with increased incidence of emotional disturbances and other psychopathology. We undertook this research to study the prevalence and severity of depression and anxiety as well as understand body image disturbances and self-esteem of the women of PCOS. We studied the relationship of depressive symptoms with self-esteem and body image disturbances.
Method A total of 105 patients diagnosed as PCOS were recruited from gynecology OPD after informed consent and ethics approval. A proforma along with Beck’s Depression Inventory, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, Body Image Concern Inventory and Rosenberg’ s Self-Esteem Scale were administered to patients for further assessment.
Results In total, 54 (51.43%) patients of PCOS had depression on BDI, 12( 11.43%) patients had body image disturbances an d 23 (21.90%) patients had a low self-esteem. A total of 21 patients( 20%) had mild and moderate depression while 5% had severe depression. Majority 53 (50.48%) of our patients had mild anxiety whereas severe to extreme anxiety was seen in about 31% of patients. Body image disturbances were seen in only 12(11.43%) patients and low self-esteem was present in 23 patients. No statistically significant correlation of depression was seen with body image or self-esteem.
Conclusions The results of this study indicate that there is a high prevalence of depression and anxiety in patients of PCOS than body image concerns and low self-esteem. Prognosis for patients would improve by liaison between gynecologist and psychiatrist.
Keywords : PCOS · Depression · Anxiety · Body Image · Self-Esteem
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age occurring in about 5 -10% of women [1]. In a recent systemic review and meta analysis Brutacalo et al. [2] reported that PCOS was associated with increased risk of diagnosis of depression, anxiety, bipolar disorder and OCD. Various researchers have reported prevalence of depression to be ranging from 13. 3–53% in their studies [3–6], with anxiety seen in about 41.9% of the patients [7]. Most patients of anxiety had higher levels of generalized and social anxiety symptoms [8]. Among Indian studies, the prevalence for depression was found to be 39% [9, 10] and 25% [11]. Chaudhari et al. [11] found mild, moderate, and severe anxiety on HARS in 62.90%, 29.60%, and 7.40%, of their sample, respectively, whereas Kaur et al. [12] using the GAD7 scale found the prevalence of anxiety to be 56%.
Women with PCOS also have greater body dissatisfaction than healthy control women with regular cycles, even after adjustment for body mass index (BMI) [13]. Experiencing high self-esteem may serve as a protective factor in coping with new and chronic illnesses, whereas low self-esteem is associated with anxiety, depression and increased reports of somatic symptoms [14, 15]. We undertook this study as there are very few Indian studies on these various aspects of PCOS. Our aim was to study the prevalence of depression, anxiety, body image disturbances and self-esteem in patients of PCOS. We also wanted to study the relationship of depressive symptoms with self-esteem and body image disturbances.
The study was a cross-sectional, observational study conducted in the outpatient department of gynecology of a general municipal hospital done over a period of one year after institutional ethics committee approval. The sample size was calculated as per the formula Z2⋅p ⋅ (100 − p) ÷ d2 ⋅p ⋅ (100 − p) ÷ d2 , where p = 38%, q = (100 − p) = 62%; Z = 1.96 ~ 2; d = Absolute error = 10%; non-responder correction -10%. The sample size of our study was 105 patients. All patients enrolled and included in the study were diagnosed by the gynecologists to be having PCOS by Rotterdam diagnostic criteria [16], patients were in the age group 18–50 years (to reduce any potential confounding effects of menopause with average age of onset being 51 years) and did not have previous history of any psychiatric illness. Patients with incomplete diagnosis of PCOS, those already under treatment for any psychiatric illness or women who were pregnant /menopausal or those having hirsutism due to related disorders like congenital adrenal hyperplasia, Cushing´s syndrome and androgen secreting tumors were excluded from the study.
Conflict of interest The authors declare that they have no conflict of interest.
Ethical statement The study was initiated after institutional ethics committee approval of Seth GSMC & KEM Hospital with reference number: IEC/14/7 /15 dated 19th Nov 2015.
Informed consent Informed consent was obtained from all individual participants included in the study. Patient consent statement was taken from each patient as per institutional ethics committee approval along with consent taken for participation in the study and publication of the scientific results/clinical information /image without revealing their identity, name or initials. The patient is aware that though confidentiality would be maintained anonymity cannot be guaranteed.
Consent for Publication Taken from all authors.
1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36.
2. Brutocao C, Zaiem F, Alsawas M, Morrow AS, Murad MH, Javed A. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta- analysis. Endocrine. 2018;62(2):318–25. https:// doi. org/ 10. 1007/ s12020- 018- 1692-3 (Epub 2018 Jul 31).
3. Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ, Moran LJ. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med. 2019;49(9):1510–20. https:// doi. org/ 10. 1017/ S0033 29171 80020 76 (Epub 2018 Aug 22).
4. Greenwood EA, Yaffe K, Wellons MF, Cedars MI, Huddleston HG. Depression over the lifespan in a population-based cohort of women with polycystic ovary syndrome: longitudinal analysis. J Clin Endocrinol Metab. 2019;104(7):2809–19.
5. Annagür B, Kerimoglu O. Psychiatric comorbidity in women with polycystic ovary syndrome. Obs gynaecology Res. 2015;41(8):1229–33. https:// doi. org/ 10. 1111/ jog. 12696 (Epub 2015 Apr 1).
6. Deeks AA, Gibson- Helm ME, Paul E, Teede HJ. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011;26(6):1399–407. https:// doi. org/ 10. 1093/ humrep/ der071 (Epub 2011 Mar 23).
7. Cooney LG, Lee I, Sammel M, Dokrae A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta- analysis. Hum Reprod. 2017;32:1075–91.
8. Emeksiz HC, Bideci A, Nalbantoğlu B, Nalbantoğlu A, Çelik C, Yulaf Y, Çamurdan MO, Cinaz P. Anxiety and depression states of adolescents with polycystic ovary syndrome. Turk J Med Sci. 2018;48(3):531–6.
9. Hussain A, Chandel RK, Ganie MA, Dar MA, Rather YH, Wani ZA, Shiekh JA, Shah MS. Prevalence of psychiatric disorders in patients with a diagnosis of polycystic ovary syndrome in Kashmir. Indian J Psychol Med. 2015;37:66–70.
10. Upadhyaya SK, Sharma A, Agrawal A. Prevalence of anxiety and depression in polycystic ovarian syndrome. Int J Med Sci Public Health. 2016;5:681–3. https:// doi. org/ 10. 5455/ ijmsph. 2016. 30072 015110.
11. Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018;40:239–46.
12. Kaur SP, Sharma S, Lata G, Manchanda S. Prevalence of anxiety, depression and eating disorders in women with polycystic ovarian syndrome in North Indian Population of Haryana. Galore Int J Health Sci Res. 2019;4(4):61–7.
13. Himelein M, Thatcher S. Polycystic ovary syndrome and mental health: a review. Obs Gynecol Surv. 2006;61:723–32.
14. Scaruffi E, Franzoi IG, Civilotti C, Guglielmucci F, La Marca L, Tomelini M, et al. Body image, personality profiles and alexithymia in patients with polycystic ovary syndrome (PCOS). J Psychosom Obstet Gynecol. 2019;40(4):294–303. https:// doi. org/ 10. 1080/ 01674 82X. 2018. 15302 10 (Epub 2018 Nov 6).
15. Tay CT, Teede HJ, Hill B, Loxton D, Joham AE. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a communitybased cohort study. Fertil Steril. 2019;112(2):353–61. https:// doi. org/ 10. 1016/j. fertn stert. 2019. 03. 027 (Epub 2019 May 2).
16. Rotterdam ESHRE. ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. https:// doi. org/ 10. 1016/j. fertn stert. 2003. 10. 004.
17. Beck AT, Steer R, Garbin M. Psychometric properties of the Beck Depression Inventory: twenty- five years of evaluation. Clin Psychol Rev. 1988;8:77–100.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
19. Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14(1):61–8.
20. Littleton HL, Axsom D, Pury CLS. Development of the body image concern inventory. Behav Res Therapy. 2005;43:229–41.
21. Rosenberg M. Society and the adolescent self-image. Princeton: Princeton University Press; 1965. p. xii–365.
22. Açmaz G, Albayrak E, Acmaz B, Bager M, Soyak M, Zararsjz G, IpekMüderris I. Level of anxiety, depression, self- esteem, social anxiety, and quality of life among the women with polycystic ovary syndrome. Sci World J. 2013;9(2013):851815. https:// doi. org/ 10. 1155/ 2013/ 851815.
23. Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M, et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet- based survey in Germany. Hum Reprod. 2009;24(6):1446–51. https:// doi. org/ 10. 1093/ humrep/ dep031 (Epub 2009 Feb 16).
24. Rasgon N, Rao R, Hwang S, Altshuler L, Elman S, Zuckerbrow- Miller J, Korenman SG. No Depression in women with polycystic ovary syndrome. Clin Biochem Correl. 2003;74:299–304.
25. Pasch L, He SY, Huddleston H, Cedars MI, Beshay A, Zane LT, Shinkai K. Clinician vs Self—ratings of Hirsutism in patients with polycystic ovarian syndrome as sociations with quality of life and depression. JAMA Dermatol. 2016;152(7):783–8.
26. Ekbäck M, Lindberg M, Benzein E, Årestedt K. Health - related quality of life, depression and anxiety correlate with the degree of hirsutism. Dermatology. 2013;227(3):278–84. https:// doi. org/ 10. 1159/ 00035 5356 (Epub 2013 Oct 4).
27. Moran LJ, Deeks AA, Teede HJ. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod. 2012;27(7):2082–8. https:// doi. org/ 10. 1093/ humrep/ des114 (Epub 2012 Apr 4).
28. Benson S, Arck PC, Tan S, Hahn S, Mann K, Rifaie N, Janssen OE, Schedlowski M, Elsenbruch S. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology. 2009;34(5):727–35. https:// doi. org/ 10. 1016/j. psyne uen. 2008. 12. 001 (Epub 2009 Jan 15).
29. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Body image satisfaction and self - esteem status among the patients with polycystic ovary syndrome. Iran J Reprod Med. 2013;11(10):829–36.
30. Pastore LM, Patrie JT, Bray MJ. Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women. J Psychosom Res. 2011;71(4):270–6. https:// doi. org/ 10. 1016/j. jpsyc hores. 2011. 02. 005 (Epub 2011 Mar 23).